Clinical Conversations: Developing biomarker tissue sampling protocols
Discussed the cost and value in biomarker testing, targeted therapies and immunotherapies.
Didactic Presenters
Susanna Greer, PhD
Stanley Hamilton, MD
Diagnosis/Pathologic staging (genetic profiling)/prognostic and predictive biomarkers
Outlined the operational issues in delivering population-based biomarker testing. Highlighted guidelines and promising practices for systemic biomarker protocol development.
Didactic Presenters
Durado Brooks, MD, MPH
Stanley Hamilton, MD
Jimmy Hwang, MD
Clinical Conversations: Enhancing communication within the oncologist-pathologist team for better care outcomes
Shared best practices related to ensuring that communication between the oncologist and pathologist occurs so that appropriate tests and samples are collected in order to make treatment decisions. Discussed timing of result and how they should be read and utilized in care.
Didactic Presenters
Susanna Greer, PhD
David N. Lewin MD, MASCP
Clinical Conversations: Referring patients for genetic counseling
Provided guidelines and recommendations when patients should be referred to genetic counseling. Outlined the evidence and value add.
Didactic Presenters
Heather Hampel, MS, LGC
Susanna Greer, PhD
Clinical Conversations: Changes in CRC incidence in under 50 age group
Discussed what we know about changing trends in this population.
Didactic Presenters
Susanna Greer, PhD
Rebecca Siegel, MPH
Quality of Life: Ensuring the best quality of life: managing comorbid conditions, providing and paying for supportive care
Discussed strategies for managing common comorbid conditions that impact patient health and wellbeing; what impact does this have on survival/outcomes and quality of life; reimbursement/payment challenges.
Didactic Presenters
Edith Mitchell, MD, MACP, FCPP
Susanna Greer, PhD
Treatment: Advances in Treatment and How to Build Patient's Treatment Continuum
Reviewed the basics of CRC Treatment. Highlighted recent treatment innovations in systemic treatment and the importance of patient selection based on tumor characteristics.
Didactic Presenters
Al Benson III, MD, FACP, FASCO
Susanna Greer, PhD
Emerging Treatments: Clinical trials
Reviewed the current clinical trial landscape and issues specific to and future directions for CRC clinical trials.
Didactic Presenters
Mark Fleury, PhD
Richard Goldberg, MD
Angela Nicholas, MD
Treatment: Management of recurrent/metastatic disease/liver resections in mCRC-potential for cure
Shared guidelines for treating patients with metastatic disease including the need for additional tissue sampling and bio-marker testing.
Didactic Presenters
Al Benson III, MD, FACP, FASCO
Durado Brooks, MD, MPH
Novel Technologies: The direction of liquid biopsy in clinical care
Discussed evidence and latest advances in liquid biopsy assays, including the anticipated impact that this technology will have on medical decision making and patient outcomes. Provided a brief overview of how this technology might be integrated into routine clinical care and existing resources to learn more.
Didactic Presenters
Kelli Bramlett
Donald Johann, MSc, MD, FACP
Access to Care: Understanding and addressing disparities in treatment access. The role of medical neighborhoods and biosimilars in increasing parity.
Highlighted current disparities in colorectal cancer treatment and discussed the role of system changes and biosimilars in increasing equity.
Didactic Presenters
Mark Fleury, PhD
Edith Mitchell, MD, MACP, FCPP
Clinical Conversations: Surveillance/Survivorship
Highlighted multidisciplinary approaches to survivorship and surveillance. Discussed the roles that a variety of health care providers can play to increase patient empowerment and engagement.
Didactic Presenters
T. Paul Nickerson, MD, FACS, FASCRS
Joya Harris, MPH
Our Experts
Al Benson III, MD, FACP, FASCO
Professor of Medicine Associate Director for Cooperative Groups
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Durado Brooks, MD, MPH
Former Vice President, Prevention and Early Detection
Richard Goldberg, MD
Director, WVU Cancer Institute
Professor, Medicine
West Virginia University
Susanna Greer, PhD
Scientific Director, Clinical Cancer Research and Immunology
Stanley Hamilton, MD
Professor of Anatomical Pathology
Frederick F. Becker Distinguished University Chair in Cancer Research
The University of Texas MD Anderson Cancer Center
Heather Hampel, MS, LGC
Associate Director, Division of Human Genetics
Associate Director, Biospecimen Research
Professor, Internal Medicine
Licensed Genetic Counselor
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Joya Harris, MPH
Director, Research Integration
American Cancer Society
Shiaowen David Hsu, MD, PhD
Associate Professor of Medicine Division of Medical Oncology
Duke Cancer Institute
Jimmy Hwang, MD
Chief, GI Medical Oncology
Director, Hematology/Medical Oncology Fellowship
Professor of Medicine
Levine Cancer Institute
Atrium Health
David N. Lewin MD, MASCP
Professor of Pathology
Director, Gastrointestinal Pathology
Medical University of South Carolina
Edith Mitchell, MD, MACP, FCPP
Clinical Professor of Medicine and Medical Oncology
Director, Center to Eliminate Cancer Disparities
Associate Director, Diversity Affairs
116th President National Medical Association
Sidney Kimmel Cancer Center at Jefferson
Angela Nicholas, MD
Chief Medical Officer
Einstein Medical Center Montgomery
T. Paul Nickerson, MD, FACS, FASCRS
Assistant Professor
Virginia Tech Carilion School of Medicine
Financial Support Provided By
Get Involved
Complete the fields below to learn more about how the American Cancer Society uses the ECHO Model to fight cancer on all fronts, inquire about an upcoming ECHO, or to learn how you can join us in our mission to save lives, celebrate lives, and lead the fight for a world without cancer.
